NCT01588730

Brief Summary

The purpose of this study is to compare the Ankle Dorsiflexion Dynasplint System (DS) to static night splint for the reduction of pain from Plantar Fasciitis (Fasciopathy).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 14, 2011

Completed
10 months until next milestone

First Posted

Study publicly available on registry

May 1, 2012

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Last Updated

August 12, 2013

Status Verified

August 1, 2013

Enrollment Period

4 years

First QC Date

July 14, 2011

Last Update Submit

August 8, 2013

Conditions

Keywords

PFDynasplintADFDAFDPlantar Fasciitisplantar Fasciopathy

Outcome Measures

Primary Outcomes (1)

  • FFI score

    The primary outcome measure will be difference between the pretreatment and two month cumulative Foot Function Index (PS-FFI) score

    16 weeks

Secondary Outcomes (1)

  • Pain subscale and SROM questionnaire

    2, 4 and 12 months

Study Arms (2)

Dynasplint

EXPERIMENTAL

Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is worn at night while sleeping (6-8 hours).

Device: Ankle Dorsiflexion Dynasplint

Static Splint

ACTIVE COMPARATOR

The control group will be treated with a static splint for a minimum of 6 4 hours each night while sleeping with the end goal of 6-8 hours.

Procedure: Commercially Available Static Night splint

Interventions

Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is worn at night while sleeping (6-8 hours) and, this does not affect activities of daily living

Dynasplint

A commericially avilable static night splint will be worn for 4-6 hours during rest.

Static Splint

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients will have had a history of at least 3 consecutive months of plantar heel pain well-localized to the plantar fascia.
  • All patients will have failed an initial treatment of non-weight bearing plantar and Achilles stretching.
  • Diagnosis will be confirmed by physical examination by a single physician (JPF) with a typical point of maximum tenderness over the medial tubercle of the calcaneus

You may not qualify if:

  • rheumatoid arthritis
  • local infection
  • pregnancy
  • patients with tumors
  • unresolved fractures
  • severe peripheral vascular disease
  • history of prior plantar fascia surgery
  • history of plantar fascia rupture
  • age \<18 years
  • recent ( within 6 weeks) steroid injection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SUN Orthopaedic Group Inc

Lewisburg, Pennsylvania, 17837, United States

Location

Related Publications (10)

  • Batt ME, Tanji JL, Skattum N. Plantar fasciitis: a prospective randomized clinical trial of the tension night splint. Clin J Sport Med. 1996 Jul;6(3):158-62.

    PMID: 8792046BACKGROUND
  • Berlet GC, Anderson RB, Davis H, Kiebzak GM. A prospective trial of night splinting in the treatment of recalcitrant plantar fasciitis: the Ankle Dorsiflexion Dynasplint. Orthopedics. 2002 Nov;25(11):1273-5. doi: 10.3928/0147-7447-20021101-20.

    PMID: 12452346BACKGROUND
  • Furia JP, Rompe JD .Extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis and Achilles tendinopathy.Curr Opin Orthop 2007;18:102-111

    BACKGROUND
  • Furia JP. The safety and efficacy of high energy extracorporeal shock wave therapy in active, moderately active, and sedentary patients with chronic plantar fasciitis. Orthopedics. 2005 Jul;28(7):685-92. doi: 10.3928/0147-7447-20050701-17.

    PMID: 16119283BACKGROUND
  • Mizel MS, Marymont JV, Trepman E. Treatment of plantar fasciitis with a night splint and shoe modification consisting of a steel shank and anterior rocker bottom. Foot Ankle Int. 1996 Dec;17(12):732-5. doi: 10.1177/107110079601701203.

    PMID: 8973894BACKGROUND
  • Powell M, Post WR, Keener J, Wearden S. Effective treatment of chronic plantar fasciitis with dorsiflexion night splints: a crossover prospective randomized outcome study. Foot Ankle Int. 1998 Jan;19(1):10-8. doi: 10.1177/107110079801900103.

    PMID: 9462907BACKGROUND
  • Probe RA, Baca M, Adams R, Preece C. Night splint treatment for plantar fasciitis. A prospective randomized study. Clin Orthop Relat Res. 1999 Nov;(368):190-5.

    PMID: 10613168BACKGROUND
  • Rompe JD, Cacchio A, Weil L Jr, Furia JP, Haist J, Reiners V, Schmitz C, Maffulli N. Plantar fascia-specific stretching versus radial shock-wave therapy as initial treatment of plantar fasciopathy. J Bone Joint Surg Am. 2010 Nov 3;92(15):2514-22. doi: 10.2106/JBJS.I.01651.

    PMID: 21048171BACKGROUND
  • Sheridan L, Lopez A, Perez A, John MM, Willis FB, Shanmugam R. Plantar fasciopathy treated with dynamic splinting: a randomized controlled trial. J Am Podiatr Med Assoc. 2010 May-Jun;100(3):161-5. doi: 10.7547/1000161.

    PMID: 20479445BACKGROUND
  • Wapner KL, Sharkey PF. The use of night splints for treatment of recalcitrant plantar fasciitis. Foot Ankle. 1991 Dec;12(3):135-7. doi: 10.1177/107110079101200301.

    PMID: 1791004BACKGROUND

MeSH Terms

Conditions

Fasciitis, Plantar

Condition Hierarchy (Ancestors)

FasciitisMusculoskeletal DiseasesFoot Diseases

Study Officials

  • John Furia, MD

    SUN Orthopaedic Group Inc

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2011

First Posted

May 1, 2012

Study Start

June 1, 2011

Primary Completion

June 1, 2015

Last Updated

August 12, 2013

Record last verified: 2013-08

Locations